My PSA score that got the urologist's attention was 4.25. A follow-up MRI indicated two tumors, both contained within the prostate, and both with a PI-RADS of 4. My biopsy showed a Gleason score of 3+4=7 (intermediate risk, favorable) and my decipher results indicated low risk, making me a candidate for active surveillance or focal therapy. I chose focal treatment because one of the tumors was abutting the edge of the prostate. I had the NanoKnife (IRE)
treatment in January 2024 at the Moffitt Cancer Center in Tampa. After the treatment, I had some relatively mild incontinence which has mostly cleared up. I also had some blood in my urine for about six weeks after the treatment, but that has totally cleared up. My sexual function is unchanged from before the treatment.

In August, my PSA was down to 1.95. The follow up multiparametric MRI (mpMRI), done the same day, showed “post ablation changes of the prostate with no new recurrent tumor in the treatment area and no new suspicious lesions in the prostate”. My doctor said that later, if there is an indication that cancer has returned, I can consider an additional IRE treatment, removal or radiation.

Best wishes for successful treatment!